We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Lu-DTPA-SC16 is a potent and safe radioimmunotherapeutic agent for testing in humans with NEPC.
No takes yet. Share an insight, caveat, or question.
Korsen et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: